130 related articles for article (PubMed ID: 35696251)
1. Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers.
Liu B; Katoh H; Komura D; Yamamoto A; Ochi M; Onoyama T; Abe H; Ushiku T; Seto Y; Suo J; Ishikawa S
J Pathol; 2022 Oct; 258(2):106-120. PubMed ID: 35696251
[TBL] [Abstract][Full Text] [Related]
2. Advancing gastric cancer precision medicine with novel genomic screens
Halmai NB; Carvajal-Carmona LG
J Pathol; 2023 Apr; 259(4):359-361. PubMed ID: 36541926
[TBL] [Abstract][Full Text] [Related]
3. In vivocharacterization of the aspartyl-tRNA synthetase DARS: Homing in on the leukodystrophy HBSL.
Fröhlich D; Suchowerska AK; Spencer ZH; von Jonquieres G; Klugmann CB; Bongers A; Delerue F; Stefen H; Ittner LM; Fath T; Housley GD; Klugmann M
Neurobiol Dis; 2017 Jan; 97(Pt A):24-35. PubMed ID: 27816769
[TBL] [Abstract][Full Text] [Related]
4. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
5. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
6. Expression Pattern of the Aspartyl-tRNA Synthetase DARS in the Human Brain.
Fröhlich D; Suchowerska AK; Voss C; He R; Wolvetang E; von Jonquieres G; Simons C; Fath T; Housley GD; Klugmann M
Front Mol Neurosci; 2018; 11():81. PubMed ID: 29615866
[TBL] [Abstract][Full Text] [Related]
7. Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data.
Li F; Li J; Yu J; Pan T; Yu B; Sang Q; Dai W; Hou J; Yan C; Zang M; Zhu Z; Su L; Li YY; Liu B
EBioMedicine; 2021 Jul; 69():103436. PubMed ID: 34157484
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
[TBL] [Abstract][Full Text] [Related]
10. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA DARS-AS1 promotes tumor progression by directly suppressing PACT-mediated cellular stress.
Yang L; Lin K; Zhu L; Wang H; Teng S; Huang L; Zhou S; Zhang G; Lu ZJ; Wang D
Commun Biol; 2022 Aug; 5(1):822. PubMed ID: 35970927
[TBL] [Abstract][Full Text] [Related]
12. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Long Noncoding RNA DARS-AS1 in Childhood Acute Myeloid Leukemia by Binding to microRNA-425.
Dou B; Jiang Z; Chen X; Wang C; Wu J; An J; Sheng G
Technol Cancer Res Treat; 2020; 19():1533033820965580. PubMed ID: 33073700
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance and prognostic value of lactate dehydrogenase A expression in gastric cancer patients.
Sun X; Sun Z; Zhu Z; Guan H; Zhang J; Zhang Y; Xu H; Sun M
PLoS One; 2014; 9(3):e91068. PubMed ID: 24608789
[TBL] [Abstract][Full Text] [Related]
15. USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.
Fu Y; Ma G; Liu G; Li B; Li H; Hao X; Liu L
Cancer Med; 2018 Nov; 7(11):5577-5588. PubMed ID: 30296012
[TBL] [Abstract][Full Text] [Related]
16. Application of next-generation sequencing in the diagnosis of gastric cancer.
Moradi N; Ohadian Moghadam S; Heidarzadeh S
Scand J Gastroenterol; 2022 Jul; 57(7):842-855. PubMed ID: 35293278
[No Abstract] [Full Text] [Related]
17. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
[TBL] [Abstract][Full Text] [Related]
18. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
Zhang C; Lin X; Zhao Q; Wang Y; Jiang F; Ji C; Li Y; Gao J; Li J; Shen L
J Cancer Res Clin Oncol; 2020 Feb; 146(2):329-342. PubMed ID: 31912229
[TBL] [Abstract][Full Text] [Related]
19. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
20. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
